Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 37272527

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Jul 13
First author
Westin JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2023 Sep 21;389(12):1152-1153. doi: 10.1056/NEJMc2309399.
    note
    Source null
    related pmid
    37733322
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Sep 21;389(12):1152-1153. doi: 10.1056/NEJMc2309399.
    note
    Source null
    related pmid
    37733323
    relationship
    Comment in

Authors and identifiers

  1. name
    Westin JR
    type
    Author
  2. name
    Oluwole OO
    type
    Author
  3. name
    Kersten MJ
    type
    Author
  4. name
    Miklos DB
    type
    Author
  5. name
    Perales MA
    type
    Author
  6. name
    Ghobadi A
    type
    Author
  7. name
    Rapoport AP
    type
    Author
  8. name
    Sureda A
    type
    Author
  9. name
    Jacobson CA
    type
    Author
  10. name
    Farooq U
    type
    Author
  11. name
    van Meerten T
    type
    Author
  12. name
    Ulrickson M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Westin JR
    type
    Author
  2. name
    Oluwole OO
    type
    Author
  3. name
    Kersten MJ
    type
    Author
  4. name
    Miklos DB
    type
    Author
  5. name
    Perales MA
    type
    Author
  6. name
    Ghobadi A
    type
    Author
  7. name
    Rapoport AP
    type
    Author
  8. name
    Sureda A
    type
    Author
  9. name
    Jacobson CA
    type
    Author
  10. name
    Farooq U
    type
    Author
  11. name
    van Meerten T
    type
    Author
  12. name
    Ulrickson M
    type
    Author
bibliography ids
  1. nci-bib-251664b0b9348581da377b65
book metadata
content sha256
1b30b132ed7ab995d1f1640791f24c1fb102882871215f6e9d1f40d86246f219
document type
citation
dois
  1. 10.1056/NEJMoa2301665
electronic publication date
display
2023 Jun 5
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37272527
immutable id
pubmed:37272527@1b30b132ed7ab995d1f1640791f24c1fb102882871215f6e9d1f40d86246f219
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
2
name
The New England journal of medicine
nlm unique id
0255562
pages
148-157
volume
389
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2023 Sep 21;389(12):1152-1153. doi: 10.1056/NEJMc2309399.
    note
    Source null
    related pmid
    37733322
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Sep 21;389(12):1152-1153. doi: 10.1056/NEJMc2309399.
    note
    Source null
    related pmid
    37733323
    relationship
    Comment in
outcomes validated
false
pmid
37272527
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
72afc004163f1b88a9caf9722ce87e5612322877ebafd334dbe7cce210a40177
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Jul 13
precision
day
year
2023
publication types
  1. Clinical Trial, Phase III
  2. Randomized Controlled Trial
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37272527/
title
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice